Description:
The panel will discuss the funding trends in the Medtech industry, and the best Corporate and IP practices for early stage Medtech companies to secure funding. The topics will include:
Funding trends for early stage Medtech companies
2019 v. 2018, 4th quarter 2019, 2020 outlook, etc.
Differences for various medical technologies (biotech, devices, healthcare IT, services, etc.) and stages (early vs. late)
2019 Exits – M&A and IPO trends
Best IP and Corporate practices
Who should attend: Life science entrepreneurs, investors, and associated service providers.
Speakers:
Roman Fayerberg-Greenberg Traurig, Shareholder & Patent Attorney
Emily Ladd-Kravitz-Greenberg Traurig, Shareholder and Corporate Attorney
TBA
About Greenberg Traurig, LLP: Greenberg Traurig, LLP (GT) has approximately 2100 attorneys in 41 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100.
Web: https:// www.gtlaw.com